Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingfei Xiaoyan Pills vs Oseltamivir for Influenza
ChiCTR1900022903Phase 4Completed
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jun 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Qingfei Xiaoyan Wan in influenza (2 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Median fever relief time. Started Jun 2019; status: completed.
02
Drugs
Qingfei Xiaoyan Wan
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR1900022903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022903.